During UQ’s giving day you can support revolutionary research to develop, characterise, design and evaluate personalised mRNA cancer vaccines.
Donate now
AIBN is solving serious problems in health, energy and the bioeconomy
using advanced biomanufacturing, precision nanomedicine and nanoengineered materials.
Our research teams are working with industry and governments to make critical strides forward and impacts in areas that include: mRNA manufacturing and vaccine development, diagnostics to discover and treat diseases, future foods and biosustainability projects reprograming cells to help the world’s biggest companies transition to net zero.
The AIBN at a glance
Part of Australia's
#1 University500+ world-class researchers
9 co-located NCRIS Facilities
Over $250m in research revenue
100+ industry partnerships
22% of UQ’s patent portfolio is generated by the AIBN
Our impact
- AIBN researchers are using organoids to transform our approach to addressing the world’s most serious health problems.
- The AIBN has the knowledge and infrastructure to ensure Australia can develop and deliver clinical-grade vaccines whenever, and wherever, they are needed.
- Developing new, cost effective technologies to remediate and protect remote sites and waterways that have been contaminated ‘forever chemicals’ (PFAS).
Latest News
-
-
Using mRNA to tackle ultra-rare mitochondrial disease
10 October 2024 -
How to sum up a PhD in three minutes with AIBN researchers
8 October 2024
Partner with us
Contact us and learn how our scientific expertise and cutting edge facilities could help you reach your goals.
